|

Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication

RECRUITINGSponsored by Copenhagen University Hospital at Herlev
Actively Recruiting
SponsorCopenhagen University Hospital at Herlev
Started2017-08-01
Est. completion2025-12-31
Eligibility
Healthy vol.Accepted

Summary

Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patient with cancer or osteoporosis, treated with antiresorptive treatment.
* The patients should have sufficient compliance, this includes willingness to have the planned assessments
* The patient should have an expected life span at enrollment of at least 2 years.
* The local bone quality and quantity should be sufficient for implant insertion without bone augmentation and is classified according to the classification by Cawood \& Howell 1988.

Exclusion Criteria:

* \> 10 cigarettes daily
* HbA1c \> 53 mmol/mol
* Poor oral hygiene
* Poor general condition: ECOG score 3 or 4.
* Poor prognosis: Expected survival \<2 year is an exclusion cause.
* Presence of metastases of the liver brain.
* Poor local jaw bone quality acc. to Cawood classification stage 3 or 4.
* Unwillingness to comply with the planned assessments and recordings

Conditions4

CancerImplantsMissing TeethOsteoporosis

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.